In focus
Latest feed
Boehringer Ingelheim’s Survodutide Shows Promise in Late‑Stage Obesity Trials
Boehringer Ingelheim’s Survodutide Shows Strong Weight‑Loss Results in Late‑Stage Trial
Eli Lilly’s Next‑Gen Obesity Pill Shows Promise for Sleep Apnea and More
PCOS: A Metabolic Rethink – Why a New Study is Shaking Up How We Understand This Condition
